Kenyon Lawrence A

EDGAR CIK 0001230484

Outlook Therapeutics, Inc. - OTLK

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO Director
Chief Financial Officer
Direct Buys
1
$28,446
5,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/26/2024
09/30/2024
Buy
5,000 @ $5.69
 $28,446 5,946 (528.54%) Direct